Literature DB >> 16388814

Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea.

Deng-Jye Yang1, Lucy Sun Hwang.   

Abstract

Conversions of statins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, from lactone forms to their corresponding hydroxy acid form in 0.1 N NaOH or 0.05 N KOH (prepared with 25, 50, 75, 90% acetonitrile or methanol in water or 100% water) were evaluated. Results showed that lactone form statins could be transformed almost completely only in alkaline solutions prepared with 25 or 50% acetonitrile. In all methanolic alkaline solutions, lactone form statins could also be converted entirely, nevertheless, they would be further transformed to the methyl ester of the hydroxy acid form and the transformation increased as methanol rises. When lactone and hydroxy acid forms of statins were in methanol, ethyl acetate, 70% acetonitrile in water (with 0.5% acetic acid or no) for 0-48 h at room temperature or in 100 degrees C water for 0-2 h, lactone form statins were converted to their corresponding hydroxy acids, which were raised as time extends and the highest conversions of them were about 35% in 100 degrees C water and 70% acetonitrile, slightly transformed for lactone form statins in 70% acetonitrile (with 0.5% acetic acid) after 8 h, and the other treatments for all statins showed no significant changes. Interferences would be reduced efficiently when statins were extracted from Pu-Erh tea with methanol, ethyl acetate or 100 degrees C water followed by purifying through a C18 solid-phase extraction cartridge. Lovastatin was the only statin found in Pu-Erh tea and the highest content of it was found under ethyl acetate extraction. In ethyl acetate and methanol extracts, lovastatin existed merely as lactone form. The lowest content of lovastatin was found in the 100 degrees C water extract of Pu-Erh tea, however, both of lactone and hydroxy acid forms were found to exist in the extract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388814     DOI: 10.1016/j.chroma.2005.12.031

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  15 in total

1.  Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.

Authors:  Kelly A Langert; Bruktawit Goshu; Evan B Stubbs
Journal:  J Neurochem       Date:  2016-12-20       Impact factor: 5.372

2.  Liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of simvastatin, lovastatin, atorvastatin, and their major metabolites in human plasma.

Authors:  Jiang Wang; Jasmine A Luzum; Mitch A Phelps; Joseph P Kitzmiller
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-01-13       Impact factor: 3.205

3.  (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase.

Authors:  Jung-Hyun Shim; Hong Seok Choi; Angelo Pugliese; Sung-Young Lee; Jung-Il Chae; Bu Young Choi; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

4.  Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.

Authors:  M Bláha; H Vlcková; L Nováková; D Solichová; P Solich; M Lánská; J Malý; V Bláha
Journal:  J Biomed Biotechnol       Date:  2010-11-07

5.  Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG).

Authors:  Hanyong Chen; Ke Yao; Xiaoyu Chang; Jung-Hyun Shim; Hong-Gyum Kim; Margarita Malakhova; Dong-Joon Kim; Ann M Bode; Zigang Dong
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

6.  The nasal delivery of nanoencapsulated statins - an approach for brain delivery.

Authors:  Adryana Clementino; Mellissa Batger; Gabriela Garrastazu; Michele Pozzoli; Elena Del Favero; Valeria Rondelli; Bianca Gutfilen; Thiago Barboza; Maria B Sukkar; Sergio A L Souza; Laura Cantù; Fabio Sonvico
Journal:  Int J Nanomedicine       Date:  2016-12-07

7.  Simultaneous Distillation Extraction of Some Volatile Flavor Components from Pu-erh Tea Samples-Comparison with Steam Distillation-Liquid/Liquid Extraction and Soxhlet Extraction.

Authors:  Xungang Gu; Zhengzhu Zhang; Xiaochun Wan; Jingming Ning; Chengcheng Yao; Wanfang Shao
Journal:  Int J Anal Chem       Date:  2010-02-10       Impact factor: 1.885

8.  Quality Characteristics and Content of Polysaccharides in Green Tea Fermented by Monascus pilosus.

Authors:  Mee-Jung Kim; Song-Suk Kim; Sang-Il Lee
Journal:  Prev Nutr Food Sci       Date:  2012-12

9.  Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.

Authors:  Gitte S Jensen; Joni L Beaman; Yi He; Zhixin Guo; Henry Sun
Journal:  Clin Interv Aging       Date:  2016-03-24       Impact factor: 4.458

Review 10.  Exploitation of Aspergillus terreus for the Production of Natural Statins.

Authors:  Mishal Subhan; Rani Faryal; Ian Macreadie
Journal:  J Fungi (Basel)       Date:  2016-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.